A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer

PURPOSE: In head and neck and bladder cancer tumor hypoxia is associated with a poor prognosis, hypoxia modification improves outcome and hypoxic status predicts benefit from treatment. Yet, there is no universal measure of clinical hypoxia. The aim of this study was to investigate whether a 26-gene...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Eustace, Amanda, Mani, Navin, Span, Paul N, Irlam, Joely J, Taylor, Janet, Betts, Guy NJ, Denley, Helen, Miller, Crispin J, Homer, Jarrod J, Rojas, Ana M, Hoskin, Peter J, Buffa, Francesca M, Harris, Adrian L, Kaanders, Johannes HAM, West, Catharine ML
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797516/
https://ncbi.nlm.nih.gov/pubmed/23820108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0542
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk